CMTU
NVO

Capital Markets Trading (UK)’s Novo Nordisk NVO Stock Holding History

Capital Markets Trading (UK)’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$452K Buy
+12,310
New +$583K 0.01% 282
2025
Q4 		– Sell
-3,946
Closed -$202K – 327
2025
Q3 		$219K Buy
+3,946
New +$231K ﹤0.01% 286

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Capital Markets Trading (UK)'s NVO Position: Q1 2026 in Review

Capital Markets Trading (UK) opened a new position in Novo Nordisk (NVO) in Q1 2026: 12,310 shares worth $452K. The stake represents 0.01% of the portfolio and ranks #282 among its holdings. This is a return to the name: Capital Markets Trading (UK) previously reported a position in NVO as recently as Q3 2025.

Capital Markets Trading (UK) first reported a position in NVO in Q3 2025 and has held it in 2 quarters since. 1,273 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Capital Markets Trading (UK) held 12,310 shares of Novo Nordisk worth $452K as of Q1 2026.
  • Novo Nordisk was a new Capital Markets Trading (UK) position in Q1 2026.
  • Novo Nordisk made up 0.01% of Capital Markets Trading (UK)'s portfolio in Q1 2026, its #282 holding.
  • Capital Markets Trading (UK) first reported a position in Novo Nordisk in Q3 2025 and has held it in 2 quarters since.
  • 1,273 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Capital Markets Trading (UK)'s 13F filing for Q1 2026, filed 15 May 2026.